EdgarLookup

SANGAMO THERAPEUTICS, INC — SC 13G/A Filings

73 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by SANGAMO THERAPEUTICS, INC (SGMO), sorted by most recent first. Each row links to the full filing on EdgarLookup. SANGAMO THERAPEUTICS, INC has filed 73 SC 13G/A documents with the SEC since 2012. To view all SEC filings by SANGAMO THERAPEUTICS, INC, see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-Q 10-Q/A 3 3/A 4 4/A 424B3 424B5 5 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER DEF 14A DEFA14A DEFR14A EFFECT FWP POS AM POSASR PRE 14A RW S-1 S-1/A S-3 S-3/A S-3ASR S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A 0000932471-24-001167 Nov 12, 2024
SC 13G/A 0000932471-24-000701 Nov 4, 2024
SC 13G/A 0001086364-24-008122 Jul 8, 2024
SC 13G/A 0000814133-24-000068 Apr 5, 2024
SC 13G/A SCHEDULE 13G/A 0001104659-24-021891 Feb 13, 2024
SC 13G/A 0000814133-24-000014 Feb 9, 2024
SC 13G/A 0001086364-24-004403 Jan 26, 2024
SC 13G/A 0000814133-23-000086 Oct 10, 2023
SC 13G/A 0000814133-23-000038 Feb 9, 2023
SC 13G/A SCHEDULE 13G/A 0001104659-23-016900 Feb 9, 2023
SC 13G/A 0001306550-23-003123 Jan 24, 2023
SC 13G/A 0000814133-22-000043 Feb 11, 2022
SC 13G/A SCHEDULE 13G/A 0001104659-22-018509 Feb 10, 2022
SC 13G/A 0000834237-22-004523 Feb 1, 2022
SC 13G/A 0000814133-21-000049 Feb 11, 2021
SC 13G/A SCHEDULE 13G/A 0001104659-21-019033 Feb 10, 2021
SC 13G/A SEC SCHEDULE 13G 0000902219-21-000302 Feb 4, 2021
SC 13G/A 0000834237-21-005567 Feb 1, 2021
SC 13G/A SCHEDULE 13G/A 0001104659-20-018542 Feb 12, 2020
SC 13G/A 0000315066-19-001338 Feb 13, 2019
SC 13G/A 0000932471-19-006119 Feb 13, 2019
SC 13G/A 0000215457-19-005593 Feb 6, 2019
SC 13G/A AMENDMENT NO. 1 0001144204-18-007920 Feb 13, 2018
SC 13G/A SANGAMO THERAPEUTICS, INC. 0000902664-18-000971 Feb 13, 2018
SC 13G/A 0000814133-18-000004 Feb 5, 2018
SC 13G/A 0000215457-18-002386 Jan 23, 2018
SC 13G/A 0000814133-17-000005 Feb 14, 2017
SC 13G/A 0000315066-17-001975 Feb 14, 2017
SC 13G/A 0000215457-17-001654 Jan 27, 2017
SC 13G/A 0000315066-16-005403 Feb 12, 2016
SC 13G/A 0000814133-16-000060 Feb 10, 2016
SC 13G/A 0000215457-16-003936 Jan 27, 2016
SC 13G/A SC 13G/A 0001144204-15-057214 Sep 29, 2015
SC 13G/A SCHEDULE 13G/A 0001144204-15-010730 Feb 19, 2015
SC 13G/A SC 13G/A 0001144204-15-010185 Feb 17, 2015
SC 13G/A ADAGE CAPITAL PARTNERS, L.P. 0000902664-15-000995 Feb 17, 2015
SC 13G/A 0000315066-15-002331 Feb 13, 2015
SC 13G/A 0001086364-15-000995 Jan 26, 2015
SC 13G/A 0000814133-14-000041 Apr 10, 2014
SC 13G/A SCHEDULE 13G/A 0000932440-14-000101 Feb 14, 2014
SC 13G/A SC 13G/A 0001144204-14-009475 Feb 14, 2014
SC 13G/A SANGAMO BIOSCIENCES, INC. 0000902664-14-000800 Feb 12, 2014
SC 13G/A 0000932471-14-004562 Feb 12, 2014
SC 13G/A 0001086364-14-001537 Jan 30, 2014
SC 13G/A SC 13G/A 0001144204-13-009039 Feb 14, 2013
SC 13G/A 0001086364-13-002410 Feb 5, 2013
SC 13G/A 0001086364-12-001384 Feb 13, 2012
SC 13G/A 0001086364-11-003707 Feb 8, 2011
SC 13G/A AMENDMENT TO STATEMENT OF ACQUISITION OF BENEFICIAL OWNERSHIP. 0001169232-09-000190 Jan 12, 2009
SC 13G/A DOC ONE 0000315066-08-004574 Dec 10, 2008